This is a preview of subscription content, log in via an institution to check access.
Reference
Cloutier M, et al. What are the real-world treatment patterns and medical costs in patients with metastatic breast cancer treated with ado-trastuzumab emtansine? 38th Annual San Antonio Breast Cancer Symposium : abstr. P4-14-03, 8 Dec 2015. Available from: URL: http://www.abstracts2view.com/sabcs15/view.php?nu=SABCS15L_710
Rights and permissions
About this article
Cite this article
Trastuzumab emtansine saves costs in HER2+ mBC. PharmacoEcon Outcomes News 745, 34 (2016). https://doi.org/10.1007/s40274-016-2775-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2775-0